Arthritis Clinical Trials in Atlanta, GA

26 recruiting studies within 50 miles

Phase

Trial	Phase	Sponsor	Dist.
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry	—	Duke University	<1 mi
Ketorolac in Upper Extremity Tendinopathy and Arthropathy	Phase 4	Emory University	<1 mi
Pectoralis Minor Release Versus Non-release in RSA	N/A	Emory University	<1 mi
A Long-term Extension Study of Ustekinumab in Pediatric Participants	Phase 3	Janssen Research & Development, LLC	<1 mi
Alpha-Defensin and Synovial Proteins to Improve Detection of Pediatric Septic Arthritis	N/A	Hospital for Special Surgery, New York	<1 mi
Persona OsseoTi Keel Compatibility Study (Total Knee Arthroplasty)	—	Zimmer Biomet	<1 mi
A Study of Dotinurad Versus Allopurinol in Participants With Gout	Phase 3	Crystalys Therapeutics	<1 mi
Preventing Injured Knees From osteoArthritis: Severity Outcomes	Phase 2	Brigham and Women's Hospital	<1 mi
Primary Subtalar Arthrodesis for Calcaneal Fractures	N/A	Wake Forest University Health Sciences	<1 mi
A Multicenter, Postmarket Surveillance Study of Subjects With the Canary canturioTM te Tibial Extension	—	Canary Medical	<1 mi
A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants	Phase 3	Janssen Research & Development, LLC	<1 mi
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer	Phase 1	National Cancer Institute (NCI)	<1 mi
The Myelin Disorders Biorepository Project	—	Children's Hospital of Philadelphia	<1 mi
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight	Phase 3	Eli Lilly and Company	6 mi
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the Knee	Phase 3	Eli Lilly and Company	6 mi
Safety and Efficacy of ABP-745 in Participants With an Acute Gout Flare	Phase 2	Atom Therapeutics Co., Ltd	17 mi
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines	Phase 3	Takeda	17 mi
A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)	Phase 4	Eli Lilly and Company	17 mi
Guselkumab vs Golimumab in PsA TNF Inadequate Responder Patients	Phase 3	University of Pennsylvania	17 mi
A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain	Phase 2	Eli Lilly and Company	26 mi
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines	Phase 3	Takeda	27 mi
A Study to Evaluate the Efficacy and Safety of Deucravacitinib in Adults With Active Sjögren's Syndrome	Phase 3	Bristol-Myers Squibb	27 mi
Nipocalimab in Moderate to Severe Sjogren's Disease	Phase 3	Janssen Research & Development, LLC	28 mi
Long Term Evaluation of Safety and Efficacy of Tildrakizumab in Patients With Psoriatic Arthritis	Phase 3	Sun Pharmaceutical Industries Limited	50 mi
Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare	Phase 2/3	Olatec Therapeutics LLC	50 mi
Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response	Phase 3	MoonLake Immunotherapeutics AG	50 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.